Innovation & intellectual property · 06/06/2005Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension to Ranolazine Patent
Summary
The U.S. Patent and Trademark Office has granted a third one-year extension to the term of U.S. Patent No. 4,567,264, which covers the medication ranolazine.
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →